New Beta Innovation Canada Limited (NBI-CA) is a biopharmaceutical manufacturer of hemoglobin-based therapeutics. Our production processes are undergoing validation for rigorous Good Manufacturing Practice (GMP) requirements. We have a state-of-the-art facility with custom-designed equipment for commercial-scale production.
Our operations include a full in-house analytical laboratory, a water purification plant, a skilled engineering team, and experts in compliance and regulatory affairs. These teams work collaboratively to ensure the safety and quality of both our processes and product. We also have a small but innovative research and development division. With headquarters in Hong Kong, NBI has a global presence in Canada, China and New Zealand.
We are a committed and innovative team who are passionate about doing great work. Work that has the potential to make a positive impact on animal and human health. We are always on the look-out for creative and passionate people who are eager to contribute to a bigger purpose.